Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01061164 · ClinicalTrials.gov registry record

IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents

A clinical trial of HIV Infections, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.

Completed
Registry status
1,207
Enrollment target
20
Study locations

NCT01061164 is a study of HIV Infections that has completed, run by International Maternal Pediatric Adolescent AIDS Clinical Trials Group. The registered enrollment target is 1,207 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (172% higher). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01061164, a study of HIV Infections, has completed, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.

COMPLETED
Registry status
1,207 participants
Enrollment target
20
Study locations

Study Summary

This study will examine the long-term effects of HIV infection, highly active antiretroviral therapy (HAART), and experimental treatments on children who participated in PACTG 219C or select IMPAACT studies.

Conditions Studied

HIV Infections

Study Locations (20)

California

  • Miller Children's Hospital Long Beach (5093) - Long Beach
  • Usc La Nichd Crs (5048) - Los Angeles
  • Childrens Hospital Los Angeles (5090) - Los Angeles
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) - Los Angeles
  • UCSD Mother, Child & Adolescent HIV Program(4601) - San Diego
  • Univ. of California San Francisco NICHD CRS (5091) - San Francisco

Florida

  • South Florida CDC Ft Lauderdale NICHD CRS (5055) - Fort Lauderdale
  • Univ. of Florida Jacksonville NICHD CRS (5051) - Jacksonville
  • Univ. of Miami Ped. Perinatal HIV/AIDS CRS (4201) - Miami
  • University of South Florida Tampa (5018) - Tampa

District of Columbia

  • Children's National Med. Ctr. Washington DC NICHD CRS (5015) - Washington D.C.
  • Howard University Washington DC NICHD CRS (5044) - Washington D.C.

Massachusetts

  • Children's Hospital of Boston NICHD CRS (5009) - Boston
  • WNE Maternal Pediatric Adolescent AIDS CRS (7301) - Worcester

Alabama

  • Univ. of Alabama Birmingham NICHD CRS (5096) - Birmingham

Colorado

  • University of Colorado Denver NICHD CRS (5052) - Aurora

Illinois

  • Chicago Children's CRS (4001) - Chicago

Louisiana

  • Tulane University (5095) - New Orleans

Trial Details

FieldValue
Enrollment Target 1,207 participants
Start Date 2009-03
Est. Completion 2014-06

Sponsor

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01061164

The ClinicalTrials.gov registry entry for NCT01061164 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,207 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (172% higher). The listed sponsor is International Maternal Pediatric Adolescent AIDS Clinical Trials Group, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT01061164 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Florida, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT01061164 about?

NCT01061164 is a clinical study titled "IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents". This study will examine the long-term effects of HIV infection, highly active antiretroviral therapy (HAART), and experimental treatments on children who participated in PACTG 219C or select IMPAACT studies.

What is the current status of trial NCT01061164?

This trial is currently completed. The enrollment target is 1,207 participants. The study started on 2009-03. Estimated completion is 2014-06.

What conditions does trial NCT01061164 study?

This clinical trial studies the following conditions: HIV Infections.

Who is sponsoring clinical trial NCT01061164?

This trial is sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01061164 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.